Biogen (BIIB) PT Lowered to $250 at BMO Capital

March 22, 2019 7:07 AM EDT Send to a Friend

BMO Capital analyst George Farmer lowered the price target on Biogen (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Biogen (BIIB) PT Lowered to $250 at BMO Capital

Member Login

Free News Feed